All Biomarkers

    GDF-15 (Growth Differentiation Factor 15)

    Inflammatory
    Aging & Cellular Stress
    pg/mL

    Growth Differentiation Factor 15 (GDF-15) is a stress-responsive cytokine released by many tissues in response to inflammation, oxidative and mitochondrial stress, and cellular senescence. Circulating GDF-15 rises consistently with age and is one of the strongest single-protein predictors of all-cause mortality, making it an emerging marker of biological aging and cumulative physiological stress.

    What It Measures

    A circulating stress-response cytokine (TGF-beta superfamily) reflecting systemic inflammation, mitochondrial/oxidative stress and cellular senescence burden.

    Optimal vs. Lab Range

    Longevity Optimal
    Lower, age-appropriate values; interpret against an age-specific reference and the trend over time.

    Target range for optimal health and longevity based on research.

    Standard Lab
    Age-dependent and assay-specific; concentrations rise with age (frequently from a few hundred up to ~1,000+ pg/mL in older adults).

    Population-based reference range from standard labs.

    Why It Matters

    GDF-15 is an emerging, well-replicated biomarker of biological aging. In long-term prospective cohorts it predicts all-cause mortality, often adding information beyond established markers such as hs-CRP and NT-proBNP, and recent analyses link genetically and epigenetically predicted GDF-15 to mortality in older adults. Levels rise with age and across many age-related diseases (cardiovascular, metabolic, renal and neurodegenerative), consistent with its role as an integrator of cumulative cellular stress. Because GDF-15 is non-specific and rises with numerous conditions, it is best used as one component of a biological-aging panel and interpreted in context rather than as a stand-alone diagnostic.

    When Low

    Lower GDF-15 (age-appropriate): lower cumulative stress/aging signal, generally favorable.

    When Optimal

    Lower, age-appropriate values are favorable; GDF-15 is continuous and interpreted against age and the reporting assay.

    When High

    Elevated GDF-15: higher inflammatory/mitochondrial-stress burden and higher statistical mortality risk; non-specific — evaluate for cardiovascular, renal, metabolic or other contributors in clinical context.

    How to Optimize

    There is no GDF-15-specific therapy; the marker is thought to reflect overall inflammatory, metabolic and mitochondrial stress. The evidence-based levers for healthy aging apply: regular physical activity, maintaining healthy body composition, not smoking, good glycemic and blood-pressure control, and treating underlying cardiovascular, renal or metabolic disease. Interpret trends over time on the same assay. This content is educational and not a substitute for medical advice.

    Key Interventions & Linked Compounds

    Emerging evidence

    Key Interventions

    Physical activity
    healthy body composition
    non-smoking
    glycemic/BP control
    treat underlying disease.

    Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

    Ordering Notes

    Specimen

    Serum/plasma immunoassay (ELISA/ECLIA)

    Patient prep

    No fasting required. Maintain usual diet and medications unless advised.

    Recommended cadence

    As part of a biological-aging panel; periodic/longitudinal on the same assay

    Reporting unit

    pg/mL

    Pre-analytic notes

    Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

    Recommended Follow-Up Actions

    1. 1

      Confirm the result is reliable

      Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift GDF-15 (Growth Differentiation Factor 15).

    2. 2

      Compare against optimal, not just lab range

      Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.

    3. 3

      Pair with related markers

      Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.

    4. 4

      Discuss interventions with a clinician

      Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.

    5. 5

      Re-test on a defined cadence

      If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.

    Testing Information

    Recommended Frequency

    As part of a biological-aging panel; periodic/longitudinal on the same assay

    Fasting Requirement

    No fasting required

    Available Test Types

    Serum/plasma immunoassay (ELISA/ECLIA)
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation